Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;53:564-570
Published online before print January 12, 2009, doi: 10.1161/HYPERTENSIONAHA.108.127035
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
53/3/564    most recent
HYPERTENSIONAHA.108.127035v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, M.-Z.
Right arrow Articles by Harris, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, M.-Z.
Right arrow Articles by Harris, R. C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*SODIUM CHLORIDE
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Biochemistry and metabolism
Right arrow Hypertrophy
Right arrow Physiological and pathological control of gene expression

(Hypertension. 2009;53:564.)
© 2009 American Heart Association, Inc.


Original Articles

Intrarenal Dopaminergic System Regulates Renin Expression

Ming-Zhi Zhang; Bing Yao; Xiaofeng Fang; Suwan Wang; James P. Smith; Raymond C. Harris

From the Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tenn.

Correspondence to Raymond C. Harris, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN. E-mail ray.harris{at}vanderbilt.edu

Dopamine is a major regulator of proximal tubule salt reabsorption and is a modulator of renin release. Dopamine has been reported to stimulate renin release in vitro through activation of D1-like receptors. However, previous studies investigating dopamine regulation of renin release in vivo have provided contradictory results, indicating stimulation, inhibition, or no effect. We have reported previously that macula densa cyclooxygenase-2 (COX-2) is suppressed by dopamine. Because macula densa COX-2 stimulates renal renin expression, our current studies investigated dopamine regulation of renal renin release and synthesis in vivo. Acute treatment with a D1-like receptor agonist, fenoldopam, significantly inhibited renin release, as did acute inhibition of proximal tubule salt reabsorption with acetazolamide. In catechol-O-methyl transferase knockout (COMT–/–) mice, which have increased kidney dopamine levels because of deletion of the major intrarenal dopamine metabolizing enzyme, there was attenuation in response to a low-salt diet of the increases of renal cortical COX-2 and renin expression and renin release. A high-salt diet led to significant decreases in renal renin expression but much less significant decreases in COMT–/– mice than wild type mice, resulting in higher renal renin expression in COMT–/– mice. In high salt–treated wild-type mice or COX-2 knockout mice on a normal salt diet, fenoldopam stimulated renal renin expression. These results suggest that dopamine predominantly inhibits renal renin expression and release by inhibiting macula densa COX-2, but suppression of renal cortical COX-2 activity reveals a contrasting effect of dopamine to stimulate renal renin expression through activation of D1-like receptors.


Key Words: dopamine • renin • kidney • COX-2 • salt reabsorption • proximal tubule • macula densa




This article has been cited by other articles:


Home page
HypertensionHome page
B. Yao, R. C. Harris, and M.-Z. Zhang
Intrarenal Dopamine Attenuates Deoxycorticosterone Acetate/High Salt-Induced Blood Pressure Elevation in Part Through Activation of a Medullary Cyclooxygenase 2 Pathway
Hypertension, November 1, 2009; 54(5): 1077 - 1083.
[Abstract] [Full Text] [PDF]